Panacea Biotec Limited (NSE:PANACEABIO)

India · Delayed Price · Currency is INR

360.00

+6.30 (1.78%)

Nov 12, 2026, 3:29 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Vaccines	4.10B	3.10B	3.60B	2.57B	2.35B
Pharmaceutical Formulations & Nutrition	2.30B	2.49B	2.00B	2.03B	4.26B
Total	6.40B	5.59B	5.59B	4.60B	6.61B

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
India	2.18B	1.58B	777.68M	1.11B	3.73B
Overseas	4.21B	4.01B	4.81B	3.49B	2.89B
Total	6.40B	5.59B	5.59B	4.60B	6.61B